Sandra Hoefgen

641 total citations
22 papers, 470 citations indexed

About

Sandra Hoefgen is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Sandra Hoefgen has authored 22 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Pharmacology and 5 papers in Organic Chemistry. Recurrent topics in Sandra Hoefgen's work include Microbial Natural Products and Biosynthesis (6 papers), Alzheimer's disease research and treatments (5 papers) and Sphingolipid Metabolism and Signaling (4 papers). Sandra Hoefgen is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Alzheimer's disease research and treatments (5 papers) and Sphingolipid Metabolism and Signaling (4 papers). Sandra Hoefgen collaborates with scholars based in Germany, United States and Netherlands. Sandra Hoefgen's co-authors include Vito Valiante, Manuel E. Than, Sven O. Dahms, Dirk Roeser, Karl‐Heinz Gührs, Bernhard Schlott, Axel A. Brakhage, Peter Hortschansky, Janis Fricke and Derek J. Mattern and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Sandra Hoefgen

22 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Hoefgen Germany 14 274 142 138 60 58 22 470
Maybelle Kho Go Singapore 14 361 1.3× 88 0.6× 79 0.6× 33 0.6× 29 0.5× 26 493
Annalaura Sabatucci Italy 13 216 0.8× 152 1.1× 25 0.2× 37 0.6× 33 0.6× 37 475
Yan‐Qiu Shi China 14 243 0.9× 65 0.5× 31 0.2× 43 0.7× 37 0.6× 22 588
Jihye Jeong South Korea 13 235 0.9× 24 0.2× 36 0.3× 37 0.6× 30 0.5× 32 520
Mariko Umemura Japan 14 316 1.2× 31 0.2× 87 0.6× 194 3.2× 39 0.7× 25 576
Michael Krohn Germany 17 279 1.0× 48 0.3× 41 0.3× 65 1.1× 130 2.2× 22 632
Xufeng Cen China 11 342 1.2× 80 0.6× 113 0.8× 60 1.0× 44 0.8× 22 691
Duane E. DeMong United States 9 233 0.9× 69 0.5× 74 0.5× 59 1.0× 109 1.9× 12 554
Ki Hong Nam South Korea 14 272 1.0× 40 0.3× 64 0.5× 18 0.3× 32 0.6× 31 482
Mhairi Nimick New Zealand 15 357 1.3× 83 0.6× 25 0.2× 80 1.3× 19 0.3× 25 603

Countries citing papers authored by Sandra Hoefgen

Since Specialization
Citations

This map shows the geographic impact of Sandra Hoefgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Hoefgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Hoefgen more than expected).

Fields of papers citing papers by Sandra Hoefgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Hoefgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Hoefgen. The network helps show where Sandra Hoefgen may publish in the future.

Co-authorship network of co-authors of Sandra Hoefgen

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Hoefgen. A scholar is included among the top collaborators of Sandra Hoefgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Hoefgen. Sandra Hoefgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janevska, Slavica, Jun Lin, Sandra Hoefgen, et al.. (2024). Optimized psilocybin production in tryptophan catabolism‐repressed fungi. Microbial Biotechnology. 17(11). e70039–e70039. 4 indexed citations
2.
Cseresnyés, Zoltán, Sandra Hoefgen, Stefan Hoffmann, et al.. (2024). The spatial organization of sphingofungin biosynthesis in Aspergillus fumigatus and its cross-interaction with sphingolipid metabolism. mBio. 15(3). e0019524–e0019524. 4 indexed citations
3.
Hoefgen, Sandra, et al.. (2024). The palmitoyl-CoA ligase Fum16 is part of a Fusarium verticillioides fumonisin subcluster involved in self-protection. mBio. 16(2). e0268124–e0268124. 2 indexed citations
4.
Hoefgen, Sandra, et al.. (2022). Intrinsic Ability of the β‐Oxidation Pathway To Produce Bioactive Styrylpyrones. Angewandte Chemie. 134(34). 1 indexed citations
5.
Hoefgen, Sandra, et al.. (2022). Desaturation of the Sphingofungin Polyketide Tail Results in Increased Serine Palmitoyltransferase Inhibition. Microbiology Spectrum. 10(5). e0133122–e0133122. 5 indexed citations
6.
Hoefgen, Sandra, et al.. (2022). Intrinsic Ability of the β‐Oxidation Pathway To Produce Bioactive Styrylpyrones. Angewandte Chemie International Edition. 61(34). e202206851–e202206851. 16 indexed citations
7.
Hoefgen, Sandra, Luka Raguž, Derek J. Mattern, et al.. (2022). Biosynthesis of the Sphingolipid Inhibitors Sphingofungins in Filamentous Fungi Requires Aminomalonate as a Metabolic Precursor. ACS Chemical Biology. 17(2). 386–394. 14 indexed citations
8.
Hoefgen, Sandra, et al.. (2022). Time‐resolved multiparameter analytics on a cell‐free production platform for acyl‐CoA precursors. SHILAP Revista de lepidopterología. 3(11-12). 289–296. 1 indexed citations
9.
Hoefgen, Sandra, et al.. (2021). Biosynthesis of Fungal Drimane‐Type Sesquiterpene Esters. Angewandte Chemie International Edition. 60(44). 23763–23770. 35 indexed citations
10.
Hoefgen, Sandra, et al.. (2021). Biosynthesis of Fungal Drimane‐Type Sesquiterpene Esters. Angewandte Chemie. 133(44). 23956–23963. 5 indexed citations
11.
Krishnan, Baiju P., Lizbeth Ofelia Prieto‐López, Sandra Hoefgen, et al.. (2020). Thermomagneto-Responsive Smart Biocatalysts for Malonyl-Coenzyme A Synthesis. ACS Applied Materials & Interfaces. 12(18). 20982–20990. 18 indexed citations
12.
Janevska, Slavica, Iuliia Ferling, Sandra Hoefgen, et al.. (2020). Self-Protection against the Sphingolipid Biosynthesis Inhibitor Fumonisin B 1 Is Conferred by a FUM Cluster-Encoded Ceramide Synthase. mBio. 11(3). 23 indexed citations
13.
Hoefgen, Sandra, Carola Graf, Lars Regestein, et al.. (2020). Rational Design of Flavonoid Production Routes Using Combinatorial and Precursor-Directed Biosynthesis. ACS Synthetic Biology. 9(7). 1823–1832. 16 indexed citations
14.
Furukawa, Takanori, Matthias Misslinger, Can Zhao, et al.. (2020). The fungal CCAAT-binding complex and HapX display highly variable but evolutionary conserved synergetic promoter-specific DNA recognition. Nucleic Acids Research. 48(7). 3567–3590. 28 indexed citations
15.
Manfiolli, Adriana Oliveira, Thaila Fernanda dos Reis, Patrick Van Dijck, et al.. (2019). Mitogen-Activated Protein Kinase Cross-Talk Interaction Modulates the Production of Melanins in Aspergillus fumigatus. mBio. 10(2). 40 indexed citations
16.
Hoefgen, Sandra, Jun Lin, Janis Fricke, et al.. (2018). Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi. Metabolic Engineering. 48. 44–51. 64 indexed citations
17.
Hoefgen, Sandra, et al.. (2014). Heparin induced dimerization of APP is primarily mediated by E1 and regulated by its acidic domain. Journal of Structural Biology. 187(1). 30–37. 20 indexed citations
18.
Hoefgen, Sandra, et al.. (2014). The Amyloid Precursor Protein Shows a pH-Dependent Conformational Switch in Its E1 Domain. Journal of Molecular Biology. 427(2). 433–442. 23 indexed citations
19.
Hoefgen, Sandra, et al.. (2014). The structural biology of the amyloid precursor protein APP – a complex puzzle reveals its multi-domain architecture. Biological Chemistry. 395(5). 485–498. 24 indexed citations
20.
Ebrahimi, Kourosh Honarmand, Christian Dienemann, Sandra Hoefgen, et al.. (2013). The Amyloid Precursor Protein (APP) Does Not Have a Ferroxidase Site in Its E2 Domain. PLoS ONE. 8(8). e72177–e72177. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maybelle Kho Go Breakdown of academic impact, for papers by Annalaura Sabatucci Breakdown of academic impact, for papers by Yan‐Qiu Shi Breakdown of academic impact, for papers by Jihye Jeong Breakdown of academic impact, for papers by Mariko Umemura Breakdown of academic impact, for papers by Michael Krohn Breakdown of academic impact, for papers by Xufeng Cen Breakdown of academic impact, for papers by Duane E. DeMong Breakdown of academic impact, for papers by Ki Hong Nam Breakdown of academic impact, for papers by Mhairi Nimick
Rankless by CCL
2026